Valley Stream, NY Nassau County

Medical Weight Loss —
Real protocols. Real results.

Supervised GLP-1 programs (Semaglutide & Tirzepatide) and non-GLP medical weight loss, designed for Valley Stream residents by an MD-led team in Cedarhurst. In-office or telehealth — wherever works for you.

5.0 ★ on Google

Am I a candidate?

  • BMI of 27+ (or 25+ with a related condition like pre-diabetes or high blood pressure)
  • No current contraindications (we screen for these at intake)
  • Committed to monthly follow-ups for dosage adjustment
  • Willing to pair medication with nutrition guidance

Not sure? The free consult is designed to answer exactly that.

Your neighbors in Cedarhurst — about 15 minutes away.

Valley Stream residents have quick access to our Cedarhurst clinic, and most follow-up visits are handled by telehealth so you can manage your program from home. We also serve Lynbrook, Malverne, and Woodmere residents across Nassau County.

Valley Stream Lynbrook Malverne Woodmere Telehealth — NY Statewide

From first call to first prescription — in under a week

We built a streamlined intake so you spend less time on logistics and more time actually losing weight.

1

Free 15-min consult

A quick call or in-office visit. We review your goals, health history, and any medications. No obligation — just clarity on what’s right for you.

2

Medical intake & lab review

A full intake with Peiman Ghatan, PA-C or Dr. Jack Fatiha covers vitals, relevant labs, and prior weight-loss history. This shapes your starting dose.

3

Your protocol is written

You receive a prescription (GLP-1 or non-GLP) along with an injection or pill schedule, starting dose, and nutritional guidance from Asal Hakim, RD.

4

Monthly telehealth check-ins

Most follow-ups are handled by telehealth — dosage adjustments, side-effect management, and progress reviews from anywhere in New York State.

5

Maintenance & transition planning

As you approach your goal, we work on a tapering strategy and long-term lifestyle plan — so results don’t end when the program does.

We match the medication to the patient — not the other way around

Not every GLP-1 is the same. Our providers choose based on your history, goals, and tolerance.

GLP-1

Semaglutide

Active ingredient in Ozempic & Wegovy

Once-weekly subcutaneous injection. Reduces appetite by mimicking the GLP-1 hormone produced after meals. Strong clinical evidence for sustained weight loss when combined with lifestyle changes.

Dual Agonist

Tirzepatide

Active ingredient in Mounjaro & Zepbound

Once-weekly injection targeting both GLP-1 and GIP receptors. Clinical trials show higher average weight loss than semaglutide alone — often recommended for patients who need a stronger response.

Non-GLP

Non-GLP Medical Weight Loss

Oral medications & adjunct therapies

For patients who are not candidates for injectable GLP-1 medications or prefer an oral-first approach. Our team evaluates FDA-approved oral options alongside nutritional and behavioral support.

An MD-led, multi-disciplinary team — all under one roof

Weight loss works best when medical supervision, clinical nutrition, and lifestyle guidance are coordinated. That’s why we built TonedMD as a team practice.

Jack Fatiha, MD — Medical Director & Co-Founder, TonedMD

Jack Fatiha, MD

Medical Director & Co-Founder

Board-certified Family Medicine. 25+ years clinical experience, 13+ years aesthetic medicine. Assistant Attending at NewYork-Presbyterian; Clinical Instructor of Family Medicine at Weill Cornell. Supervising physician for all weight-loss programs.

Peiman Ghatan, PA-C — Co-Founder, Physician Assistant, TonedMD

Peiman Ghatan, PA-C

Co-Founder, Physician Assistant

NY-licensed PA with 5+ years in internal medicine, family practice, and urgent care. Focuses on obesity, metabolic conditions, GLP-1 & non-GLP therapy, and injectables. Leads initial weight-loss intakes.

Asal Hakim, RD — Registered Dietitian, TonedMD

Asal Hakim, RD

Registered Dietitian

Personalized, evidence-based nutrition counseling with a focus on realistic, sustainable habits. Lives in the Five Towns and brings a community-rooted perspective to every patient plan.

What patients ask before their first visit

Do you serve patients from Valley Stream, NY?
Yes. Valley Stream residents are just about 15 minutes from our Cedarhurst clinic at 409B Central Avenue. Most follow-up visits after your initial intake can also be handled by telehealth, so once you’ve been screened in-person, you can manage your program from home anywhere in New York State.
Am I a candidate for Semaglutide or Tirzepatide?
Most adults with a BMI of 27 or above — or a BMI of 25 with a weight-related health condition like pre-diabetes or hypertension — may qualify. Our provider reviews your full health history and lab work before recommending any GLP-1 medication.
Do you offer telehealth for weight loss follow-ups?
Yes. Once your initial in-office screening is complete, most follow-up visits — including dosage adjustments and progress reviews — can be handled by telehealth from anywhere in New York State.
What’s the difference between Semaglutide and Tirzepatide?
Semaglutide (the active ingredient in Ozempic and Wegovy) is a GLP-1 receptor agonist. Tirzepatide (Mounjaro/Zepbound) activates both GLP-1 and GIP receptors, which studies show produces greater average weight loss. Our providers will recommend the right medication based on your goals and medical history.
What happens at the initial weight loss screening?
You’ll meet with our provider for a health history review, vitals, and — if appropriate — lab requisition. We discuss your previous attempts at weight loss, lifestyle factors, and medical history to build a protocol that fits your life. The visit takes roughly 45 minutes.

Ready to find out if you qualify?

A free 15-minute consult is the first step. No pressure — just a straightforward conversation about your goals and your options.

409B Central Avenue, 2nd Floor · Cedarhurst, NY 11516 · Mon–Thu 10am–6pm · Sun 10:30am–1:30pm

More from TonedMD

Individual results vary; no specific outcome is guaranteed. GLP-1 medications are not right for everyone and can have serious side effects. Your provider will review your medical history, contraindications, and potential risks before prescribing. We follow FDA-approved labeling and clinical guidelines.